Jazz Pharmaceuticals plc - SHS USD (JAZZ)

CUSIP: G50871105

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / SHS USD
Total 13F shares
52,094,206
Share change
+2,374,567
Total reported value
$5,741,576,836
Put/Call ratio
198%
Price per share
$110.34
Number of holders
376
Value change
+$270,141,092
Number of buys
178
Number of sells
208

Quarterly Holders Quick Answers

What is CUSIP G50871105?
CUSIP G50871105 identifies JAZZ - Jazz Pharmaceuticals plc - SHS USD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2020

As of 30 Jun 2020, Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by 376 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,094,206 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, LSV ASSET MANAGEMENT, AQR CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, FMR LLC, STATE STREET CORP, Nuveen Asset Management, LLC, and CITADEL ADVISORS LLC. This page lists 377 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.